Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 1 , Page 145, February 2009

Corrigendum to “Androgens and prostate cancer” [Best Practice & Research Clinical Endocrinology & Metabolism 2008; 22 (4): 601–613]

Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, SE-901 85 Umeå, Sweden

Article Outline

 

The authors regret that Reference 77 was incorrect in the above issue. The correct version is given below:

Gould DC, Kirby RS. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer? Prostate Cancer Prostatic Dis. 2006;9(1):8–14.

The authors apologise for any inconvenience caused.

PII: S1521-690X(09)00017-7

doi:10.1016/j.beem.2009.02.002

Refers to article:

  • Androgens and prostate cancer risk

    Sara Wirén, Pär Stattin
    Best Practice & Research Clinical Endocrinology & Metabolism August 2008 (Vol. 22, Issue 4, Pages 601-613)

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 1 , Page 145, February 2009